Revisiting the therapeutic potential of tocotrienol

[thumbnail of 463210_early_in_press.pdf]
463210_early_in_press.pdf - Accepted Version (8MB) | Preview
Available under license: Creative Commons Attribution

Ranasinghe, Ranmali ORCID: 0000-0003-3634-2689, Mathai, Michael ORCID: 0000-0001-8783-2122 and Zulli, Anthony ORCID: 0000-0002-2660-078X (2022) Revisiting the therapeutic potential of tocotrienol. BioFactors. ISSN 0951-6433


The therapeutic potential of the tocotrienol group stems from its nutraceutical properties as a dietary supplement. It is largely considered to be safe when consumed at low doses for attenuating pathophysiology as shown by animal models, in vitro assays, and ongoing human trials. Medical researchers and the allied sciences have experimented with tocotrienols for many decades, but its therapeutic potential was limited to adjuvant or concurrent treatment regimens. Recent studies have focused on targeted drug delivery by enhancing the bioavailability through carriers, self-sustained emulsions, nanoparticles, and ethosomes. Epigenetic modulation and computer remodeling are other means that will help increase chemosensitivity. This review will focus on the systemic intracellular anti-cancer, antioxidant, and anti-inflammatory mechanisms that are stimulated and/or regulated by tocotrienols while highlighting its potent therapeutic properties in a diverse group of clinical diseases.

Dimensions Badge

Altmetric Badge

Item type Article
DOI 10.1002/biof.1873
Official URL
Subjects Current > FOR (2020) Classification > 3208 Medical physiology
Current > Division/Research > Institute for Health and Sport
Keywords tocotrienol, tocotrienol group, pathophysiology, epigenetic modulation, computer remodelling
Citations in Scopus 7 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login